share_log

HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Raises Price Target to $20

Benzinga ·  Aug 11, 2023 07:51

HC Wainwright & Co. analyst Mitchell Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and raises the price target from $17 to $20.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment